WATSON 885 Pill — YELLOW ROUND, 9mm — Lisinopril
| Imprint | WATSON / 885 |
|---|---|
| Colour | YELLOW |
| Shape | ROUND |
| Size | 9 |
| Strength | LISINOPRIL 30 mg |
| Dosage form | Tablet |
| Manufacturer | REMEDYREPACK INC. |
| NDC | 49349-391 |
| Schedule | — |
| Availability | — |
| Ingredients | LISINOPRIL[LISINOPRIL ANHYDROUS] |
What does this imprint mean?
The imprint "WATSON 885" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.
Active ingredient
Lisinopril
Uses and warnings
BOXED WARNING: BOXED WARNING - FETAL TOXICITY: "When pregnancy is detected, discontinue Lisinopril Tablets as soon as possible." ACE inhibitors can cause injury and death to developing fetuses, particularly during the second and third trimesters. Key warnings include: - Angioedema: Can occur at any time; may involve face, lips, tongue, or airway—potentially fatal - Renal impairment: Monitor kidney function; risk of acute renal failure in vulnerable patients - Hypotension: Risk especially in heart failure, volume depletion, or concurrent diuretic use - Hyperkalemia: Monitor potassium levels; increased risk with renal insufficiency or diabetes | BOXED WARNING - FETAL TOXICITY: "When pregnancy is detected, discontinue Lisinopril Tablets as soon as possible." ACE inhibitors can cause injury and death to developing fetuses, particularly during the second and third trimesters. Key warnings include: - Angioedema: Can occur at any time; may involve face, lips, tongue, or airway—potentially fatal - Renal impairment: Monitor kidney function; risk of acute renal failure in vulnerable patients - Hypotension: Risk especially in heart failure, volume depletion, or concurrent diuretic use - Hyperkalemia: Monitor potassium levels; increased risk with renal insufficiency or diabetes
Lisinopril is indicated for: treatment of hypertension in adults and pediatric patients 6 years and older; adjunct therapy for heart failure; and reduction of mortality following acute myocardial infarction. The medication works by lowering blood pressure to reduce risk of cardiovascular events like strokes and heart attacks.
How to identify this pill
- • Check the imprint matches exactly: "WATSON 885".
- • Confirm the colour (YELLOW) and shape (ROUND).
- • Compare the size (9) against a ruler if possible.
- • When in doubt, confirm with a pharmacist before taking any medication.
Similar-looking pills
USL 100
YELLOW ROUND · Topiramate
2632 V
YELLOW ROUND · Cyclobenzaprine
LOTENSIN 10
YELLOW ROUND · Benazepril
APO PRA
YELLOW ROUND · Pravastatin
WATSON 348
YELLOW ROUND · Hydrochlorothiazide
IG 283
YELLOW ROUND · Cyclobenzaprine
R 717
YELLOW ROUND · Diclofenac
B
YELLOW ROUND · Benzonatate
12 5
YELLOW ROUND · Furosemide
MP 657
YELLOW ROUND · Clonidine
K 7
YELLOW ROUND · Cyclobenzaprine
TL177
YELLOW ROUND · Cyclobenzaprine
Other pills of Lisinopril
42 10
WHITE CAPSULE · Lisinopril
E 152
WHITE ROUND · Lisinopril
4214 V
WHITE ROUND · Lisinopril
LL B01
BLUE HEXAGON (6 SIDED) · Lisinopril
H 146
PINK CAPSULE · Lisinopril
10
WHITE ROUND · Lisinopril
LUPIN 40
YELLOW ROUND · Lisinopril
L 27
BLUE ROUND · Lisinopril
RX534
RED ROUND · Lisinopril
LUPIN 10
PINK ROUND · Lisinopril
WATSON 409
YELLOW ROUND · Lisinopril
E25
WHITE OVAL · Lisinopril
Official references
Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 33ae8d02-1cf3-302d-e054-00144ff8d46c.xml